相互作用
Ledipasvir-sofosbuvir + Tipranavir
重症度: 併用禁忌
Ledipasvir-sofosbuvir and Tipranavir: contraindicated interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Tipranavir, given with ritonavir, induces P-glycoprotein and is expected to lower ledipasvir and sofosbuvir exposure considerably. This may compromise the antiviral response and lead to treatment failure.
この相互作用をわかりやすく説明すると
Ledipasvir-sofosbuvir and Tipranavir are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.
Ledipasvir-sofosbuvir belongs to Anti Virals; Tipranavir belongs to Anti Virals.
なぜ起こるのか
Tipranavir/ritonavir induces intestinal P-glycoprotein, reducing absorption of ledipasvir and sofosbuvir.
対処法
Avoid coadministration as labeled; use an alternative antiretroviral regimen or a different hepatitis C regimen in consultation with an HIV/HCV specialist.
薬剤師に尋ねること
- Is there an alternative to one of these two medicines for me?
- If both are essential, who is monitoring me and how often?
- Which symptoms mean I should stop and seek help straight away?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Ledipasvir-sofosbuvirとTipranavirの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Ledipasvir-sofosbuvirのその他の相互作用
Tipranavirのその他の相互作用
よくある質問
Can I take Ledipasvir-sofosbuvir with Tipranavir?
MediHelp rates the interaction as contraindicated. Ledipasvir-sofosbuvir and Tipranavir are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Tipranavir, given with ritonavir, induces P-glycoprotein and is expected to lower ledipasvir and sofosbuvir exposure considerably. This may compromise the antiviral response and lead to treatment failure.
How serious is the interaction between Ledipasvir-sofosbuvir and Tipranavir?
MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid coadministration as labeled; use an alternative antiretroviral regimen or a different hepatitis C regimen in consultation with an HIV/HCV specialist.
What other medicines interact with Ledipasvir-sofosbuvir?
MediHelp also lists interactions of Ledipasvir-sofosbuvir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Ledipasvir-sofosbuvir page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
